Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Year founded1993
Served areaWorldwide
Headcount3,030
HeadquartersEssener Bogen 7, 22419 Hamburg – Germany
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
20.01.23 | Lanthaler, Dr. Werner | Board | Other | EUR 468,010.50 |
20.01.23 | Lanthaler, Dr. Werner | Board | Other | EUR 467,992.56 |
20.01.23 | Johnstone, Dr. Craig | Board | Other | EUR 173,415.65 |
20.01.23 | Johnstone, Dr. Craig | Board | Other | EUR 173,397.70 |
20.01.23 | Dohrmann, Dr. Cord | Board | Other | EUR 165,627.74 |
20.01.23 | Spillner, Enno | Board | Other | EUR 114,737.13 |
20.01.23 | Dohrmann, Dr. Cord | Board | Other | EUR 110,412.51 |
18.01.23 | Gurdal, Hakan | Board | Buy | EUR 493,900.00 |
14.06.22 | Lanthaler, Dr. Werner | Board | Buy | EUR 228,559.35 |
14.06.22 | Lanthaler, Dr. Werner | Board | Buy | EUR 226,873.95 |
DE0005664809
LEI529900F9KI6OYITO9B12
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryOddo BHF Corporates & Markets AG
Listed Stock ExchangeMDAX
TecDAX
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.